SCHEMBL4811932

SCHEMBL4811932

COC(=O)CCc1cn(C(=O)Sc2ccccc2)c2ccc(OC)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.53
MTNR1A P48039 5/20 0.48
AKR1C3 P42330 6/20 0.48
MTNR1B P49286 4/20 0.48
AKR1C2 P52895 2/20 0.47
NQO2 P16083 1/20 0.47
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
RAB9A P51151 1/20 0.44
AKR1C4 P17516 1/20 0.44
PTGS1 P23219 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PLA2G2A P14555 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3025302 0.84 HTR6 (0.73) HTR6MTNR1AAKR1C3MTNR1BAKR1C2
SCHEMBL3018944 0.82 HTR6 (0.53) HTR6MTNR1AAKR1C3MTNR1BAKR1C2
SCHEMBL3032670 0.80 HTR6 (0.52) HTR6MTNR1AAKR1C3MTNR1BAKR1C2
SCHEMBL15242222 0.80 MTNR1A (0.70) HTR6MTNR1AMTNR1BNQO2PPARG
SCHEMBL5654827 0.78 HTR6 (0.54) HTR6MTNR1AAKR1C3MTNR1BAKR1C2
SCHEMBL3036311 0.78 MTNR1A (0.74) HTR6MTNR1AMTNR1BPPARGPPARD
SCHEMBL3030043 0.76 PPARG (0.75) HTR6PPARGPPARDPPARA
SCHEMBL3029516 0.75 HTR6 (0.76) HTR6MTNR1AAKR1C3AKR1C2PPARG
SCHEMBL3034823 0.74 PPARG (0.55) HTR6MTNR1AAKR1C3MTNR1BAKR1C2
SCHEMBL24878466 0.73 HTR6 (0.53) HTR6MTNR1AAKR1C3MTNR1BAKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348338-B2 PPAR active compounds PLEXXIKON, INC. (US) 2008-03-25 US disclosed
US-20050288354-A1 PPAR active compounds PLEXXIKON, INC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288354-A1 PPAR active compounds PPARG, PPARD, PPARA HTR6 1004/4885MTNR1A 488/4885AKR1C3 3189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.